Changes in growth factor expression in the ageing prostate may disrupt epithelial-stromal homeostasis

被引:17
作者
Slater, M [1 ]
Barden, JA
Murphy, CR
机构
[1] Univ Sydney, Inst Biomed Res, Sydney, NSW 2006, Australia
[2] Univ Sydney, Dept Anat & Histol F13, Sydney, NSW 2006, Australia
来源
HISTOCHEMICAL JOURNAL | 2000年 / 32卷 / 06期
基金
英国医学研究理事会;
关键词
D O I
10.1023/A:1004065630631
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The alterations in expression of six growth factors known to be regulators of prostatic function have been examined in the ventral lobe of prostates from young adult (14 week) acid ageing (1.5 year) Wister rats. The selected growth factors were transforming growth factor beta (TGF beta 1), insulin-like growth factor I (IGF-I), insulin-like growth factor II (IGF-II), platelet derived growth factor (PDGF), basic fibroblast growth factor (FGF2) and epidermal growth factor (EGF). The extracellular matrix growth co-factor thrombospondin (TSP) was also examined. Our study demonstrated a 2.9-fold up-regulation of TGF beta 1 (p < 0.0001), a 2.0-fold increase in FGF2 (p < 0.0002), an 8.3-fold increase in IGF-II (p < 0.0007) and a 5.4-fold increase in EGF (p < 0.0001) in ageing compared to adult prostate tissue. Conversely, we observed a 2.7-fold down-regulation of IGF-I (p < 0.0005), a 1.7-fold decrease in PDGF (p < 0.0097) and a 5.8-fold decrease in TSP (p < 0.0079) in ageing rat prostate tissue. The observed alterations ill growth factor expression in this study may be: the result or cause of, an imbalance in the proliferative-apoptotic balance during ageing. This imbalance may explain the increase in epithelial proliferation that is characteristic of the normal ageing prostate. As in other systems it seems likely that these factors work synergistically rather than in isolation.
引用
收藏
页码:357 / 364
页数:8
相关论文
共 47 条
[1]  
Albrecht DE, 1997, J BIOL CHEM, V272, P2236
[2]   Castration-induced apoptotic cell death in the Brown Norway rat prostate decreases as a function of age [J].
Banerjee, S ;
Banerjee, PP ;
Brown, TR .
ENDOCRINOLOGY, 2000, 141 (02) :821-832
[3]  
BARCLAY AN, 1981, IMMUNOLOGY, V42, P593
[4]   IMMUNOPATHOLOGY OF RENAL-ALLOGRAFT REJECTION ANALYZED WITH MONOCLONAL-ANTIBODIES TO MONONUCLEAR CELL MARKERS [J].
BISHOP, GA ;
HALL, BM ;
DUGGIN, GG ;
HORVATH, JS ;
SHEIL, AGR ;
TILLER, DJ .
KIDNEY INTERNATIONAL, 1986, 29 (03) :708-717
[5]  
BRASS AL, 1995, CANCER RES, V55, P3197
[6]  
CechowskaPasko M, 1996, ACTA BIOCHIM POL, V43, P557
[7]  
COLOMBEL MC, 1995, METHOD CELL BIOL, V46, P369
[8]  
Cunha GR, 1996, ACTA ANAT, V155, P63
[9]  
CUNHA GR, 1992, J ANDROL, V13, P465
[10]  
Farrugia A, 1991, Transfus Med, V1, P31, DOI 10.1111/j.1365-3148.1991.tb00006.x